| Year |
Citation |
Score |
| 2005 |
Ono HA, Davydova JG, Adachi Y, Takayama K, Barker SD, Reynolds PN, Krasnykh VN, Kunisaki C, Shimada H, Curiel DT, Yamamoto M. Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer. Journal of Gastroenterology. 40: 31-42. PMID 15692787 DOI: 10.1007/S00535-004-1490-Y |
0.538 |
|
| 2004 |
Zhu ZB, Makhija SK, Lu B, Wang M, Kaliberova L, Liu B, Rivera AA, Nettelbeck DM, Mahasreshti PJ, Leath CA, Barker S, Yamaoto M, Li F, Alvarez RD, Curiel DT. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter. Cancer Gene Therapy. 11: 256-62. PMID 15017380 DOI: 10.1038/Sj.Cgt.7700679 |
0.621 |
|
| 2004 |
Mi J, Barker S, Meuse L, Sawatzki S, Hartigan-O'Connor D, Chamberlain JS. 460. Immunogenicity of E2b-Deleted Adenoviral Vectors Compared with First Generation Vectors Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.426 |
0.316 |
|
| 2003 |
Barker SD, Dmitriev IP, Nettelbeck DM, Liu B, Rivera AA, Alvarez RD, Curiel DT, Hemminki A. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma. Gene Therapy. 10: 1198-204. PMID 12833129 DOI: 10.1038/Sj.Gt.3301974 |
0.623 |
|
| 2003 |
Lam JT, Bauerschmitz GJ, Kanerva A, Barker SD, Straughn JM, Wang M, Barnes MN, Blackwell JL, Siegal GP, Alvarez RD, Curiel DT, Hemminki A. Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids. Cancer Gene Therapy. 10: 377-87. PMID 12719707 DOI: 10.1038/Sj.Cgt.7700578 |
0.617 |
|
| 2003 |
Barker SD, Coolidge CJ, Kanerva A, Hakkarainen T, Yamamoto M, Liu B, Rivera AA, Bhoola SM, Barnes MN, Alvarez RD, Curiel DT, Hemminki A. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy. The Journal of Gene Medicine. 5: 300-10. PMID 12692864 DOI: 10.1002/Jgm.341 |
0.655 |
|
| 2003 |
Nagi P, Vickers SM, Davydova J, Adachi Y, Takayama K, Barker S, Krasnykh V, Curiel DT, Yamamoto M, Sugerman HJ. Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement Journal of Gastrointestinal Surgery. 7: 364-371. PMID 12654561 DOI: 10.1016/S1091-255X(02)00437-7 |
0.552 |
|
| 2003 |
Hakkarainen T, Hemminki A, Pereboev AV, Barker SD, Asiedu CK, Strong TV, Kanerva A, Wahlfors J, Curiel DT. CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 619-24. PMID 12576427 |
0.452 |
|
| 2002 |
Bauerschmitz GJ, Barker SD, Hemminki A. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review). International Journal of Oncology. 21: 1161-74. PMID 12429964 DOI: 10.3892/Ijo.21.6.1161 |
0.566 |
|
| 2002 |
Arafat WO, Gómez-Navarro J, Buchsbaum DJ, Xiang J, Wang M, Casado E, Barker SD, Mahasreshti PJ, Haisma HJ, Barnes MN, Siegal GP, Alvarez RD, Hemminki A, Nettelbeck DM, Curiel DT. Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv. Gene Therapy. 9: 256-62. PMID 11896464 DOI: 10.1038/Sj.Gt.3301639 |
0.59 |
|
| 2002 |
Kanerva A, Mikheeva GV, Krasnykh V, Coolidge CJ, Lam JT, Mahasreshti PJ, Barker SD, Straughn M, Barnes MN, Alvarez RD, Hemminki A, Curiel DT. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 275-80. PMID 11801569 |
0.482 |
|
| 2001 |
Casado E, Gomez-Navarro J, Yamamoto M, Adachi Y, Coolidge CJ, Arafat WO, Barker SD, Wang MH, Mahasreshti PJ, Hemminki A, Gonzalez-Baron M, Barnes MN, Pustilnik TB, Siegal GP, Alvarez RD, et al. Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 2496-504. PMID 11489832 |
0.639 |
|
| 2001 |
Barker SD, Casado E, Gomez-Navarro J, Xiang J, Arafat W, Mahasreshti P, Pustilnik TB, Hemminki A, Siegal GP, Alvarez RD, Curiel DT. An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites. Gynecologic Oncology. 82: 57-63. PMID 11426962 DOI: 10.1006/Gyno.2001.6226 |
0.619 |
|
| 2000 |
Xiang J, Gómez-Navarro J, Arafat W, Liu B, Barker SD, Alvarez RD, Siegal GP, Curiel DT. Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer. The Journal of Gene Medicine. 2: 97-106. PMID 10809143 DOI: 10.1002/(Sici)1521-2254(200003/04)2:2<97::Aid-Jgm99>3.0.Co;2-S |
0.608 |
|
| Show low-probability matches. |